Cozad Asset Management Inc Moderna, Inc. Transaction History

Cozad Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$118.38 - $210.04 $118 - $210	-1 Reduced 0.06%	1,725 $309,000
Q2 2022 Aug 09, 2022	BUY	$117.13 - $176.59 $4,568 - $6,887	39 Added 2.31%	1,726 $247,000
Q1 2022 Apr 29, 2022	BUY	$126.46 - $235.05 $14,542 - $27,030	115 Added 7.32%	1,687 $291,000
Q4 2021 Feb 01, 2022	BUY	$225.82 - $368.51 $80,617 - $131,558	357 Added 29.38%	1,572 $399,000
Q3 2021 Nov 05, 2021	BUY	$221.9 - $484.47 $26,628 - $58,136	120 Added 10.96%	1,215 $468,000
Q2 2021 Jul 29, 2021	BUY	$129.91 - $234.98 $142,251 - $257,303	1,095 New	1,095 $257,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Cozad Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cozad Asset Management Inc with notifications on news.